Dry Age-related Macular Degeneration Clinical Trial
The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03046407 -
Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04566445 -
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
|
Phase 2 | |
| Recruiting |
NCT04339764 -
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05536752 -
QA102 Phase II Study in Subjects With Dry AMD
|
Phase 2 | |
| Recruiting |
NCT06351605 -
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
|
||
| Active, not recruiting |
NCT04065490 -
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
|
N/A | |
| Recruiting |
NCT06229665 -
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)
|
Phase 2/Phase 3 | |
| Completed |
NCT01002950 -
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
|
Phase 2 | |
| Active, not recruiting |
NCT03333954 -
Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration
|
N/A | |
| Completed |
NCT05667688 -
Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85
|
Phase 1 | |
| Completed |
NCT03144999 -
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
|
Phase 1 | |
| Withdrawn |
NCT04511936 -
Microcurrent Stimulation for Dry Age-related Macular Degeneration
|
N/A | |
| Withdrawn |
NCT04358471 -
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
|
Phase 2 | |
| Terminated |
NCT04643886 -
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration
|
Phase 2 | |
| Not yet recruiting |
NCT05418231 -
Observation of the Natural Course of Age-related Macular Degeneration
|
||
| Recruiting |
NCT00926861 -
Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD
|
N/A | |
| Active, not recruiting |
NCT04437368 -
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
|
Phase 2 | |
| Active, not recruiting |
NCT03894020 -
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
|
||
| Not yet recruiting |
NCT04875234 -
Vision Improvement for Legally Blind Dry AMD Patients
|
||
| Recruiting |
NCT02755428 -
Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
|
Phase 1/Phase 2 |